AMP Acta Medica Peruana

XXXXXX XXXXXX

INSTRUCTIONS FOR AUTHORS

ABOUT THE JOURNAL Average me for a response: An ini al 15-day me period will be established,
although this may be extended up to 2 months, depending on how complex
the topic may be or on the availability of specialized reviewers. This me
• Focus and scope period may be extended once again if a second review round is required.
Acta Medica Peruana (AMP) is the official scien fic publica on of the Objec on withdrawal stage: Observa ons by external reviewers and/or
Peruvian College of Physicians; its objec ve is to spread medical knowledge editors will be sent to the corresponding author of the manuscript (the one
to the medical and scien fic community both na onally and interna onally. who submi ed the paper), and he/she will be given a fixed me period for
withdrawing these observa ons/objec ons. This may take up to 2 weeks,
AMP receives original contribu ons related with all medical special es, i.e., but it may be extended, depending on the manuscript author(s). The system
clinical, surgical, as well as those dealing with public health issues, basic screen will display the words ‘Under review’ (‘Revisión’).
sciences, and medical educa on, both in Spanish and in English.
A er the response from the author(s), the fellow editor in charge verifies
that the observa ons are correctly withdrawn (response le er properly
• Process for editorial management filled, document with control change version, etc.) and submits this
The editorial management process encompasses from the me a manuscript corrected version of the manuscript to the Editorial Commi ee. This stage
is received up to its poten al publica on. Here are some addi onal details may be repeated more than one me.
in this respect: Average me for a response: Fi een days as a minimum, but this may be
extended if agreed so by the reviewer and the Editorial Commi ee. This me
Manuscript recep on. The author sends his/her request for his/her paper period may be extended once again if a second review round is required.
to be published through the OJS-AMP system website. The system assigns
a code for the material and inserts it in a schedule in order to undergo Final decision by the Editorial Committee: After having reviewed the
assessment by the Editorial Commi ee. The editorial assistant systema cally corrected version of the manuscript, the Editorial Commi ee decides
assigns papers to fellow editors on a first come, first served basis. The whether it is accepted or rejected. If accepted, the manuscript enters the
system automa cally establishes the ‘Submission’ (‘Envío’) status of the edi on stage (the system screen will display ‘Editorial’); if rejected, a le er
submi ed material. suppor ng this decision will be sent to the author(s).
Average me for a response: Seven to fi een days.
Average me for a response: Seven days for receiving a communica on
from the assistant editor. Paper edi on: This is the stage where the text is edited in order to adapt it to
AMP style or for improving its wording. If necessary, the fellow editor in charge
Assessment by the Editorial Commi ee. The fellow editor in charge performs may communicate with the author(s) in order to withdraw some observa ons.
he first review of the manuscript. If formal requisites are complied with
(format, word count, reference system, etc.), he/she will review the Average me for a response: Fi een to thirty days, depending on the amount
manuscript and he/she will present his/her views on it in the next ordinary of correc ons necessary.
mee ng of the Editorial Commi ee. The system screen will display the words
‘Under review’ (‘Revisión’). If this is not the case, the submi ed manuscript Design, layout and submission for prepress proofing: In this stage, the
may be rejected and the reason for that will be stated (the system screen manuscript is given a format according to AMP style, and a prepress
will display the word ‘Rejected’ (‘Rechazado’). proofing final version is prepared. This document, which is in PDF format,
is sent to the corresponding author so he/she may approve it. If there is no
Afterwards, the Editorial Committee evaluates the manuscript and response to this communica on, the Editorial Commi ee will assume it has
determines if it complies with AMP assessment criteria and requests an been automa cally approved, so no other changes will be made in the final
evalua on by external reviewers (peer review). In case of non-compliance, version. The me for approving this prepress proofing is up to five days,
the manuscript is rejected. but this may vary, with a prior communica on, according to the discre on
of the Editorial Commi ee.
Average me for a response: Seven to fi een days for the evalua on by
the Editorial Commi ee. Average me for a response: Seven days for submi ng the prepress proofing
version. This may take up to five days when wai ng for the final response
Peer review process: In this stage, external reviewers are invited for assessing by the author(s).
the manuscript. They perform a specialized evalua on of its contents. They
are selected on the basis of their competence in the par cular topics to Final version and publica on of a new paper: This is the last phase of the
be reviewed. editorial process. The paper is published in the OJS-AMP system and it
becomes available in its complete version. A erwards, other formats for
External reviewers evaluate the manuscript according to its originality, the paper will be made available (XML; HTML, etc.) in order to submit the
per nence, and relevance. The assessment may end sugges ng accep ng paper to databases where AMP is indexed and its profile may be improved.
the manuscript, making some observa ons and reques ng clarifica on,
so the manuscript may be reassessed later, a er having responded to the Average me for a response: Fi een days for the paper to appear in the
iden fied objec ons, or, otherwise, the material may be rejected. OJS-AMP website.

This review stage has an established me period which may take from one
week to one month, depending on the reviewer(s)’ availability. If there is
• Payments by recep on or publica on
an even number of reviewers, the opinion of an addi onal reviewer will be AMP journal has no fees for the publica on of ar cles submi ed by the
requested. The system screen will display the words ‘Under review’ (‘Revisión’). authors, nor payment by manuscripts recep on.

Acta Med Peru. 2020

Instruc ons for authors

EDITORIAL POLICY • Open access policy

Acta Medica Peruana (AMP) gives free immediate open access to its
• Ethical regula ons for publica on contents, based on the principle that states that giving the public free
Acta Medica Peruana (AMP) follows ethical standards for scien fic research access to scien fic research helps global knowledge exchange. AMP uses
and publica on; therefore, when research has been carried out in humans, it the interna onal Crea ve Commons 4.0 A ribu on.
is necessary to men on that the study has been approved by an Ins tu onal
Ethics Commi ee. The Editorial Commi ee reserves its right to request • An -plagiarism policy
documented proof for this approval.
AMP adheres itself to the recommenda ons of the Commi ee in Publica on
The following manuscripts do not require an approval by an Ins tu onal Ethics (COPE; https://publicationethics.org) and the International
Ethics Commi ee: 1) Studies using public domain secondary databases, Commi ee of Medical Journal Editors (ICMJE). AMP reviews all poten al
including systema c reviews, meta-analyses, and bibliometric studies; misconducts against publica on ethics, such as plagiarism, redundant
2) Public health surveillance interven ons; 3) Research on outbreaks or publica on, data manipula on and inven on, as well as any infringement
sanitary emergency events; 4) Public health program evalua ons; and 5) related with authorship and ins tu onal affilia on(s). Every manuscript
Educa onal evalua ons scheduled within academic curricula. submi ed to AMP will undergo review by an -plagiarism so ware.

The following manuscripts do require an approval by an Ins tu onal Should plagiarism be found during the publica on process, the manuscript
Ethics Commi ee: 1) Research performed in human beings; 2) Research will be rejected; if found a er the paper had been published, a rec fica on
directly using human biological material or data from poten ally iden fiable will be issued. A erwards, a communica on will be sent to the ins tu ons
human beings, such as data from biobanks or medical records. This case will where the author(s) is/are affiliated, following COPE recommenda ons.
apply as long as the previously presented excep ons may not be applicable.
• Copyright policy
The Editorial Commi ee suggests following the recommenda ons from
these regula ons and those from na onal and interna onal instances: AMP adheres to the Interna onal Crea ve Commons 4.0 License (CC BY 4.0).
The World Medical Associa on Declara on of Helsinki (WMA, 2013), the Therefore, 1) Authors maintain their copyright and guarantee to AMP that
WMA declara on on Ethical Considera ons for Healthcare and Biobanks this is the first me their work is published, as long as the CC BY 4.0 license
Data Bases (2016), the International Ethical Regulations for Health is adhered to; 2) Authors may adopt other non-exclusive distribu on license
Related Research in Humans issued by the Council for Interna onal for their manuscript, as long as the ini al AMP publica on is cited; and 3)
Organiza ons of Medical Sciences (CIOMS) in coopera on with the Authors may have the capability to spread their work.
World Health Organiza on (WHO) (2017) and the Peruvian Regula ons for
Clinical Trials (Supreme Decree N° 021-2017-SA and its updated versions). • Data preserva on policy
Ethics for publica on Acta Medica Peruana (AMP) adheres to the LOCKSS system for paper
collec on, preserva on, and storage (h ps://amp.cmp.org.pe/index.
Acta Medica Peruana (AMP) adheres to the recommenda ons issued by php/AMP/gateway/lockss).
the Commi ee in Publica on Ethics (COPE; h ps://publica onethics.
org) and the Interna onal Commi ee of Medical Journal Editors (ICMJE). • Complaint management policy
AMP ac vely looks for poten al faults against publica on ethics, such as
Acta Medica Peruana (AMP) reviews every submi ed manuscript in a
plagiarism, redundant publica on, data manipula on and inven on, as
transparent and objec ve manner. AMP decides if a manuscript may be
well as those related with authorship and ins tu onal affilia on(s). Should
published according to consensus reached by the members of the Editorial
such situa ons occur during the publica on process, the manuscript will
Commi ee, being peer reviewing the main basis for making any decision
be rejected; in case the paper has been published, a rec fica on will be
on that respect. Nonetheless, it is established that any author may request
issued. This will take place a er a proper inves ga on of the case has been
a reassessment of the decision taken by AMP in case he/she should not
performed and a er the implicated author(s) had exerted their proper
agree with this decision; he/she may also request manuscript withdrawal at
defense, following COPE flow charts. In both cases, competent ins tu ons
any stage of the editorial process if he/she may deem it necessary. If doing
will be informed, i.e. the ins tu ons where the author(s) work, their
so, he/she may communicate through the OJS-AMP system or by sending
financing par es, their corresponding professional organiza ons and ethical
a message to the following e-mail: [email protected].
commi ees that had approved the study, when appropriate. Also, the Ethics
and Deontology Commi ee of the Peruvian College of Physicians will be
informed, if deemed necessary. AUTHORS
In case of doubt about any ethical misconduct, author(s) may contact • Instruc ons for authors
the Editorial Committee in order to obtain adequate orientation
Acta Medica Peruana (AMP) is the official scien fic publica on of the
([email protected]).
Peruvian College of Physicians; its objec ve is to spread medical knowledge
to the medical and scien fic community both na onally and interna onally.
Poten al conflicts of interests of members of the Editorial Commi ee
It publishes papers in Spanish or English, on a quarterly basis.
Any manuscript including any member of AMP Editorial Commi ee is not
AMP only receives original contribu ons (related with all medical special es,
exempt from complying with the requisites specified in these instruc ons,
clinical, surgical, as well as those dealing with public health issues, basic
and manuscripts to be processed will follow the same pathway that has
sciences, and medical educa on). These contribu ons may be included
been outlined for any paper; nonetheless, the process will take place
within the following categories:
without the par cipa on of the involved Editorial Commi ee member. This
means he/she will not be able to par cipate in any session regarding that
• Editorial
par cular manuscript (decision, review), and he will not know the names
• Original papers
of the assigned reviewers. Also, members of the Editorial Commi ee will
• Short original papers
have to declare their poten al conflicts of interest with respect to that
• Review ar cles
par cular manuscript, and they will inhibit themselves from decision
• Case reports
making on that issue.

Acta Med Peru. 2020

 Instruc ons for authors

• Special ar cles Academic degrees or professional groups are not determinants for
• History of medicine establishing authorship(s) in a manuscript. Only contribu ons for developing
• Le ers to the editor the manuscript according to established authorship criteria must be taken
into account.
Every manuscript received by AMP is primarily evaluated by the Editorial
Commi ee; if deemed as of interest for publica on, if complying with Fundraising, data collec on, or general supervision of the research group
formal requirements of instruc ons for authors, as well as with ethical per se does not jus fy authorship. This informa on should be included in
and methodological requisites, it will undergo peer review (experts in this the acknowledgement sec on. Every author must detail what were his/
par cular field) before being considered for publica on. her specific contribu ons for the manuscript and this informa on will be
included in the paper, due to transparency reasons.
The Instruc ons for authors follow recommenda ons from the Interna onal
Commi ee of Medical Journal Editors (ICMJE), the World Associa on of With respect to the order of appearance for the authors; in general, the
Medical Editors (WAME), the Commi ee on Publica ons Ethics (COPE), as first author is the one that worked the most and who wrote the first dra
well as with requisites stated by SciELO and MEDLINE. of the manuscript, and the last author usually is the junior researcher in
the team. Every paper must state a single corresponding author. There may
be excep onal cases when two corresponding authors may be included.
General considera ons
These individuals are the ones that will be contacted by AMP with respect
to the editorial process.
First page
Those persons that may be included within the author list not complying
It must include the following:
with authorship criteria are called honorary authors. The aforemen oned
inclusion is considered as an ethical misconduct. Persons excluded from
• Title in Spanish and English; preferably, with a 20-word maximum
the author list are considered as ghost authors and this situa on also is
extension. Also, a 10-word or less secondary tle may be included.
considered as an ethical misconduct. In case any person should consider he/
• Authors list, including the following informa on for each one of them: she has been excluded from authorship, he/she may send a communica on
- Name (as they may want it to appear in the publica on) and data sta ng the evidence that he/she complied with authorship criteria. Should
base. AMP detect this misconduct, COPE rules will be applied.
- Affilia on (two as a maximum; one ins tu onal and the other
academic). Every author must include his/her ins tu onal affilia on(s), which must
- Professional group and specialty, also, the highest academic degree correspond to the ins tu on where he/she is currently working or studying,
obtained. and that may have contributed in some way for the development of research
- Current e-mail. to be published. Up to two affilia ons per author may be included. The
- ORCID number for each author. ‘independent author’ term is also accepted.
• Authorship contribu ons. Contribu ons from each author for the
manuscript must be clearly stated. These must comply with the four The corresponding author must send the following data: address, telephone
points stated by ICMJE and must be presented in detailed in the sworn number, and e-mail. Any communica on with respect to manuscript review
affidavit. and edi on will be sent to this author.
• Financing source.
Authors must show the way in which they wish their name(s) should appear
• Disclosure of poten al conflicts of interest. Every rela onship, condi on, in the publica on and in the data bases. They should take into account that
or circumstance that might affect objec veness when interpre ng the data bases are wri en in English and that they only consider the last name
paper must be declared. This may be an economical or ins tu onal as surname. Here we show some ways for presen ng names and how they
potential conflict (consultancy, scholarships, travel grants, travel would appear in data bases:
allowances, etc.). The response generated when using the COI format
must be included. Table 1. Examples for coding authors’ names in data bases.
• Acknowledgements (when appropriate, and sta ng the reason).
• Corresponding author, his/her address, telephone number, and e-mail. As it appears in
Name sent for publica on
data bases
Authorship and ins tu onal affilia on(s) If sent as it appears in the ID document
The complete list of involved persons, their order of appearance, and their Daniel Alcides Carrion Garcia Garcia DAC
ins tu onal affilia ons are the sole responsibility of the signing authors. Daniel Carrion Garcia Garcia DC
Every authorship conflict or any ethical issues related with this will be se led
according to the COPE rules. If the author wishes his/her both surnames may
appear together
Recogni on of who is the author is based on ICMJE recommenda ons; Daniel Alcides Carrion-Garcia Carrion-Garcia DA
therefore, each author must comply with these four criteria, with no
excep ons: Daniel Carrion-Garcia Carrion Garcia D
If the author wishes only his father surname may
1) Significant contribu ons for conceiving or designing the manuscript, appear
or contribu ons for data collec on, analysis, or interpreta on;
2) Every important writing contribution or critical review of the Daniel Alcides Carrion Carrion DA
manuscript contents; Daniel Carrion Carrion D
3) Final approval of the version to be published; and
4) Assume responsibility with respect to every aspect dealt with in If the author is be er known by his/her second name
the manuscript, aiming to guarantee that every issue related with D. Alcides Carrion Carrion DA
accurateness or integrity of any sec on in the paper will be adequately
looked for and solved. D. Alcides Carrion-Garcia Carrion-Garcia DA

Acta Med Peru. 2020

Instruc ons for authors

Summary and keywords or in currently used sta s cal packages. Other images may be presented
using TIFF or JPG formats, with >600- dpi or >300- pixel resolu on, and they
Every ar cle, except Editorials and Le ers to the Editor, must have a
should be added in different archives, so that appropriate edi on may be
summary in Spanish and in English. Also, key words in Spanish must be
made, aiming to obtain a proper layout. Legends for micrographs must state
included, using Health Sciences Descriptors (h p://pesquisa.bvsalud/
power and staining method(s). Maps must have a scale.
org/portal/decs-locator/?lang=es) and MeSH NLM (h ps://www.
ncbi,nlm.nih.gov.mesh) for keywords in English, five words as a minimum
Should any figure show patients’ faces, a dark area must be placed
and eight words as maximum.
covering their eyes so they may not be iden fied; also, authors must
a ach wri en authoriza on from pa ents or their legal representa ves
References
allowing their consent in case of publishing photographs that might allow
Only those references cited within the text will be included, as a single their iden fica on. If a previously published figure is included, the origin
reference [1], or if more than one reference is included [5–8], following a source must be stated and a wri en permission from the copyright holder
correla ve order and between brackets. Vancouver format must be used, must be sent to AMP.
according to the ICMJE (h ps://www.nlm.nih.gov/bsd/unbiform_
requirements.html). In case there are more than six authors, the first six Considera ons for style
will be included followed by ‘et al’. Also, the reference tle may include a
link directed towards the website where the reference may be accessed to, AMP uses the Interna onal System of Units. Scien fic names of species
as long as the electronic version is available. Every reference must include must be wri en using italics. Colons (,) are used for decimals in Spanish
its DOI number, when corresponding. Here we present some examples and dots (.) in English. Titles of papers must not have abbrevia ons. Should
for references: abbrevia ons be used in the text, the complete name must be placed and
then the abbrevia on between brackets a er its first men on. The use
Published papers of abbrevia ons is not recommended for items appearing less than four
mes in the paper. For sta ng percentages, a single decimal (i.e. 10.1%) is
Marmot M. Universal health coverage and social determinants of health. recommended. When men oning popula ons less than 50 individuals, the
Lancet. 2013; 382 (9900): 1227-8. doi: 10.1016/S0140-6736(13)61791-2. use of percentages is not recommended, only frac ons should be used (i.e.
Sanchez Clemente N, Ugarte-Gil CA, Solorzano N, Maguiña C, Pachas P, 20/50). When using associa on measurements such as odds ra os (OR) and
Blazes D, et al. Bartonella bacilliformis: a systema c review of the literature their confidence intervals (CI), the use of two decimals is recommended
to guide the research agenda for elimina on. PLoS Negl Trop Dis. 2012; 6 (i.e. OR; 2, 15; 95% CI: 1,10–3, 41). For p-values, up to three decimals may
(10): e1819. doi: 10.1371/journal.pntd.0001819. be used (i.e. p= 0,009).

Books
• Sending papers
Hulley SB, Cummings SR, Browner WS, Grady DG, Newman TB. Designing
clinical research. 4th ed. Philadelphia: Lippinco , Williams & Wilkins; 2013. Every manuscript submi ed to AMP must be wri en in Spanish or English,
it must not have been previously par ally or totally published, it must
Chapters in books not have been previously submi ed to other publica on, whatever the
language might be.
McMillan W. Theory en healthcare educa on research: the importance of
worldview. In: Cleland J, Durning SJ (editors). Researching medical educa on.
Manuscripts should be submitted alongside the mandatory required
Oxford: Willey Blackwell; 2015. p. 25-34.
documents through our OJS-AMP pla orm: h p://amp.cmp.org.pe.
Thesis
Mandatory documents
Pesce H. La epidemiología de la lepra en el Perú [Tesis Doctoral]. Lima:
Facultad de Medicina, Universidad Nacional Mayor de San Marcos; 1961. First of all, the author(s) must register as so in our OJS-AMP pla orm,
through the ‘REGISTRATION’ (‘REGISTRARSE’) menu. They will receive an
Website e-mail with their user name and password so they may access the system.
Interna onal Commi ee of Medical Journal Editor [website]. Defining the role Then, the author(s) should produce or enter the following requisites:
of authors and contributors. Vancouver: ICMJE; 2015 [accessed on February
1st, 2016]. Available at: h p://www.icmje.org/ recommenda ons/ 1) A complete version of the manuscript, including the first page
browse/roles-andresponsibili es/defining-the-role-of-authors-and- requirements (see the following sec on). The document must be in
contributors.html. Word, A4 paper sheets, 2.5- cm margin, and 11-point size font, single-
spaced.
Tables 2) All authors must be included in the OJS system.
These must be presented a er the references, each in a different page. 3) Every author must have an ORCID number within the OJS system.
Tables must be orders using Arabic numbers and they must include all 4) A sworn affidavit properly filled and signed.
necessary informa on, both contents and tle, so they may be interpreted 5) A format disclosing conflict(s) of interest for every author, as
without the need for going back to the text. Only a single horizontal line recommended by ICMJE.
separa ng the table tle from its body will be accepted. In no case ver cal
lines shall be accepted. Tables must be wri en using Word or Excel, no image • Structure and types of papers
formats (.jpg, .png, etc.) will be accepted, since tables must be presented in
a format that is amenable for diagramming. All abbrevia ons and symbols AMP publishes different types of papers according to its editorial policy. The
used in the table must include their explana on(s) on their inferior part. following table shows the maximum word length and other characteris cs
for the published papers:
Figures
Sec ons
Sta s cs graphs, flow charts, diagrams, photographs, maps, or correla vely
ordered numeric charts may be included as figures, and they may be placed AMP adheres itself to the Equator-Network ini a ve (h ps://www.
a er tables. Sta s cs graphs and flow charts may be presented in Excel equator-network.org), and recommends all authors to follow the

Acta Med Peru. 2020

 Instruc ons for authors

Table 2. Maximum length admi ed for publica on, according to sec on(s).

Summary Contents Figures and

Paper type Peer review Authors References
(words) (words) tables
Editorial* Yes NL NA 1500 1 15
Original paper Yes NL 250 3500 6 40
Short communica on Yes NL 150 2000 3 25
Case report Yes 6 150 2000 4 25
Review ar cle Yes NL 150 5000 6 70
Special ar cle Yes NL 150 3500 6 50
History of medicine Yes 5 150 3000 4 25
Le er to the editor (comment) Yes 3 NA 500 1 5
Le er to the editor (scien fic) Yes NL NA 1000 1 10
NA: not applicable; NL: no limit.
*At AMP request

guidelines adjus ng to their study design. From 2021 on, the presenta on of the used method with its corresponding references, and also the cutoff
of the check list included in this ini a ve will be mandatory, according to points may be included in case categorical variables are used.
the paper type. o Procedures or interven ons. These are precisely described, so that
any posterior replica on of the study may be feasible. Medicinal
Editorial plant collec on and iden fica on procedures are described when
they are used. Pharmaceu cal products and chemical compounds
This is presented under express request from AMP Editorial Commi ee; are to be properly iden fied, men oning their ac ve ingredient(s),
its contents must refer to a specific topic of interest about clinical prac ce, generic name(s), dose, and administra on route(s).
public health ma ers, issues related to medical ac vi es or ethics, or AMP o Data analysis. Here how data is treated is described, including quality
management or editorial policy. Editorials must have a specific tle. control for data bases, sta s cal so ware, p-values deemed as
significant, tests used for variable assessment, data on assump on
Original papers compliance and the ways in which models for mul ple variables had
been developed in case of use.
These are products of original scien fic research, and they must be related to o Ethical considerations. This describes the approval by Ethics
a topic of interest for AMP. These are mainly studies using a prospec ve and Commi ees, obtained authoriza ons, informed consent/assent, data
analy cal design, with a sample size that is adequate for the research ques on. confiden ality, and result return when appropriate.
• Abstract. This is structured including objec ve(s), materials and methods, • Results. There must be clearly presented, not including opinions or
results, and conclusions. It must be wri en in Spanish and English. interpretations; unless they should correspond to statistical issues.
• Keywords. These must be five as a minimum and eight as a maximum. Tables and texts must have a men on within the text, without repea ng
They must be wri en in Spanish and English. BIREME “science health the informa on. These may include sub tles in order to facilitate their
descriptors” must be used (h p://DeCS.bvs.br/) must be used for Spanish interpreta on.
and MeSH from NLM (www.ncbi.mlm-nih.gov/mesh) for English. • Discussion. Here the main results are presented, which may respond to
• Introduc on. This must be brief, going from general to specific features; it the study objec ves. Results are compared with those from other trials,
usually encompasses less than 20% of the total length of the paper. It must differences or similari es are presented, and reasons for this are stated.
include what is known (relevant background), what is not known (related Limita ons (bias) may be presented in this sec on, explaining why such
with the ques on of research), and what it is to be done (objec ves). findings do not invalidate the results obtained. Here, clinical implica ons
• Materials and Methods. Here the used methodology is described, so of all findings are presented in detail, sta ng their importance for
that it would allow the study to be reproduced and data quality may research or public health, and recommenda ons may be issued. Finally,
be evaluated. It is recommended to review interna onal consensus conclusions summarizing the discussion may be presented, based on
for presen ng papers, according to the study design; i.e. STROBE for obtained results and responding to the study objec ves.
observa onal studies, CONSORT for clinical trials, PRISMA for systema c
reviews, SRQR for qualitative studies, and CHEERS for economic Short communica ons
evalua ons. These tools may be found in www.equator-network. These are also inves ga on products; and, due to their objec ves, design,
org. The use of sub tles is recommended, including the following or results, they may be published using a format not exceeding 2000 words
informa on as appropriate: (see Table 2). These are par cularly case series, non-probabilis c descrip ve
o Study design. Here the study design is presented, alongside its dates and studies or small retrospec ve studies. They follow the same structure as that
the place where it has been performed; describing the relevant issues of an original ar cle. The summary differs from that of an original ar cle
that may help the reader for understanding the condi ons in which the because it must not exceed 150 words, and it is not structured.
study had taken place and that might be useful in the discussion sec on.
o Study popula on. Here the study popula on is described, together Review ar cles
with the selec on criteria, sample size calcula ons and power as
appropriate, sampling design and enrolling characteris cs. It shows These products should include a wide literature review, they should belong
a flow chart describing how par cipants had been enrolled. to the areas of interest of AMP, and they must follow this structure: have
o Variables. Here the main study variables are described (relevant a non-structured 150-word summary, keywords, introduc on, contents
dependent and independent variables), so that the variable to be assessed (structured according to the author’s discre on), discussion (including
has been assessed in the most appropriate manner, indica ng the validity conclusions), and references.

Acta Med Peru. 2020

Instruc ons for authors

Case reports professionals, members of renowned research ins tu ons. The Editorial
Commi ee will decide whether the manuscript is accepted for entering the
These products may include from one to ten cases describing an unusual
editorial process under these circumstances: 1) if it is in line with its editorial
condi on, an atypical presenta on of a common condi on, unknown
line; 2) if it fits well into AMP sec ons; and 3) if it brings new informa on,
adverse events, rare disease associa ons, cases described for the first me
has a sound methodology with the problem under inves ga on, and if it
in Peru, new interven ons or new uses for drugs. All of these situa ons
has been properly wri en; then it may go to the peer review process. If
must have a clear message or lesson for the medical community. The
that is not the case, the submi ed material will not be accepted and it will
use of CARE guide is recommended for preparing case reports (www.
be returned to the author(s).
equator-network.org). These products have the following structure:
non-structured summary, keywords, introduc on (which generally describes
the known facts), case report, discussion (where the learned lessons • Peer review
or contribu ons from presented cases are featured), and references.
Informa on that may help in iden fying pa ent(s) must not be included. Peer review aims to guarantee the quality of the papers to be published.
In case photographs where it is unavoidable to show the pa ent’s face This is a double-blinded review. Reviewers are selected on the basis of their
because of his/her condi on, an explicit authoriza on from him/her or his/ exper se in a par cular area (proven through their publica ons and their
her legal representa ve must be included. Figures and photographs must academic achievements), or according to their exper se on methodological
be high quality, and they should be independently presented using .jpg or issues (i.e. biosta s cs, epidemiology specialists). This review is ad honorem.
. ff archives. A physician must always be the corresponding author, and Every reviewer has the obliga on of declaring every possible conflict of
trea ng physicians should be amongst other authors. interest regarding the paper to be reviewed and inhibit himself/herself
from the review; also, he/she should maintain confiden ality with respect
Special ar cles to the data included n the paper.

These may be essays, opinion papers, clinical prac ce guides, systema za on Ra ng may be as follows: a) accepted with no modifica ons; b) may be
papers, research protocols, or experience reports that might be of interest published, with minor observa ons; c) may be published, with major
for clinical prac ce, medical educa on, healthcare policy or being related to observa ons; d) should not be published. Also, the reviewer may suggest
medical professional ac vity. These ar cles have the following structure: a the paper is published in a different sec on of AMP (i.e., as an original paper
not more than 150-word non-structured summary, keywords, introduc on, instead of a short communica on).
contents (structured according to the author’s discre on), discussion
(including conclusions), and references. Taking into account the reviewers’ observa ons, the Editorial Commi ee will
finally decide whether the paper may be published, if it is not approved, or if it
History of Medicine is necessary to send a document with objec ons/observa ons to the author(s).
Topics for historical review that are relevant in medical fields will be included.
These may also include notes about deceased Peruvian physicians. These Response to observa ons
pieces do not have a summary, their structure is according to the author’s In case it has been decided that the manuscript may go to the peer review
discre on, and the whole piece may include up to 2000 words. process, and when reviewers’ conclusions become available, authors should
respond to observa ons in the following way:
Le ers to the Editor
Scientific Letters. These pieces show systematically obtained results. The author will send observa on withdrawal including the following: 1)
Generally these are descrip ve inves ga ons using small non-probabilis c a corrected version of the manuscript, showing change control, and 2)
samples. These pieces may include case series or case reports showing a le er detailing each one of the observa ons made, his/her response
specific results of interest or requiring fast-track publica on. Scien fic le ers to such observa ons and ac ons taken. An inadequate response of such
can have up to 1000 words and they are presented without a summary. observa ons may become a reason for reques ng addi onal clarifica on
These may also cons tute a response to a previously published ar cle in and even for rejec ng the manuscript. AMP may resend the corrected
a former issue of AMP. manuscript to a reviewer before considering it for publica on.

Comment Le ers. In the case of non-scien fic le ers (describing inves ga on Should the author not respond within the established me period or of he/
results), their extension may be up to 5000 words, five references one figure she does not send a le er detaining his/her response to each requested
or table, and up to three authors. These le ers may be a response to an objec on/observa on, the manuscript will be rejected.
ar cle published in a former issue of AMP, therefore, extending the peer
review process, and they may also correspond to evidence-based opinions The average las ng me for the editorial process (from recep on up to
about areas related to medical educa on, healthcare policy, being related to the final decision of the Editorial Commi ee) may last between two to
medical professional ac vity, or complaints related to ethical misconducts four months, depending on the review process and the authors’ response.
with respect to some ar cle published in AMP. Implicated authors have the
right to respond in the same or in the following issue. In excep onal cases Prepress proofing
there might be a rejoinder. Once edi on is over, the paper will be sent for diagramma on. A erwards,
the diagrammed paper will be sent to the author(s) so they may verify that
• ORCID it corresponds to the final approved text, and then finally they may give
their approval for publica on. Should authors not respond within the me
Every author of every manuscript submi ed for poten al publica on to Acta framework established by AMP for this purpose, this final version will be
Medica Peruana must have an ORCID iden fier (h ps://orcid.org/signin) deemed as accepted.
that must be included within the documents a ached to their evalua on
request. Not including this requisite may be a reason for not accep ng a
manuscript for evalua on by the Editorial Commi ee. • Contact
Every communica on between the authors and the Editorial Commi ee
PROCESS FOR PAPERS REVIEW must be carried out through the following e-mail: actamedicaperuana@
cmp.org.pe or by telephone, at +511 213 1400 (extension 2602). Requests
Manuscripts submi ed to OJS-AMP will be presented and placed under for evalua on and publica on will only be made possible through our
considera on of the Editorial Commi ee, which is cons tuted by healthcare OJS-AMOP system.

Acta Med Peru. 2020